Healthcare News

Eascra Biotech, a nanomedicine startup, with a lab in Worcester, Massachusetts, has appointed Dr. Andrew Goodearl, Ph.D., as Chief Scientific Officer.

Eascra Biotech has been awarded a NASA In Space Production Applications (InSPA) Phase 2 contract, valued at $7.96 million.

REYKJAVIK, ICELAND (August 27, 2026) — Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide,...

REYKJAVÍK (27. ágúst 2026) — Alvotech (NASDAQ: ALVO, ALVO SDB) tekur þátt í tveimur fjárfestaráðstefnum í Bandaríkjunum í næsta mánuði þar sem Róbert Wessman, stofnandi og starfandi stjórnarformaður,...

REYKJAVIK, Iceland, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for...

Received First LockeT Purchase Order Through Cardinal Health which serves approximately 90% of U.S. Hospitals though its Medical Products business  Johns Hopkins Hospital, a world-renowned academic...

BOSTON, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Rectify Pharmaceuticals, Inc. (“Rectify”), a biotechnology company advancing Positive Functional Modulators (PFMs), a novel class of oral small molecules...

Data supports ongoing registration Phase 3 trial in r/r PTCL, Phase 2 trial in atopic dermatitis and planned trials for hidradenitis suppurativa and asthma  Data in T cell lymphoma demonstrated...

HOUSTON, TX, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL) (the “Company” or “Nexalin”), announces that its board of directors has approved a 1-for-30 reverse stock split...

Phase 1 single- and multiple-ascending dose study in healthy volunteers evaluating the pharmacokinetics and safety of SLTE-1009; Topline safety and pharmacokinetic data expected mid-2027 RALEIGH,...